Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients First ACCCESS patient expected
OKX becomes Training Kit Partner of Premier League Champions Manchester City
The new agreement will see OKX become Official Training Kit partner for the 2022/23 season. To celebrate the announcement, OKX has commissioned renowned street artist
ROSEN, A TOP RANKED LAW FIRM, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TDOC
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health,
OKTA DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Okta, Inc. Investors with Losses to Secure Counsel Before Important July 19 Deadline in Securities Class Action – OKTA
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Okta,
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages IonQ, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – IONQ
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IonQ,